ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,449,000 | +318.1% | 49,096 | +210.8% | 0.03% | +233.3% |
| Q4 2020 | $2,021,000 | -78.1% | 15,797 | -80.8% | 0.01% | -75.0% |
| Q3 2020 | $9,239,000 | -12.0% | 82,104 | -25.5% | 0.04% | -32.1% |
| Q2 2020 | $10,503,000 | +2244.4% | 110,241 | +2111.0% | 0.05% | +1666.7% |
| Q1 2020 | $448,000 | -0.9% | 4,986 | -56.5% | 0.00% | +50.0% |
| Q3 2019 | $452,000 | +11.3% | 11,449 | +61.5% | 0.00% | +100.0% |
| Q3 2018 | $406,000 | – | 7,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |